alexa Abstract | Comparison of Efficacy and Tolerability of Vitamin C as add on Therapy to the oral hypoglycaemic agent in newly diagnosed Type 2 Diabetes Mellitus

International Journal of Drug Development and Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Background: Diabetes mellitus is one of the most common metabolic disorders that causes microvascular and macro vascular complications. No study has ever examined the effect of vitamin C with glibenclamide on fasting (FBS) and postprandial blood sugar (PPBS) as well as glycosylated hemoglobin (HbA1c) in the treatment of type 2 diabetes mellitus (DM). Objective: The goal was to examine the effect of oral vitamin C with glibenclamide on FBS, PPBS in type 2 DM.. Methods: Ninety newly diagnosed Type 2 DM patients participated in a Randomized, open lable prospective study for 8-weeks. Newly diagnosed Type 2 DM patients were randomly divided into three groups .First group received glibenclamide 5mg orally,second group received glibenclamide 5mg with vitamin C 1g orally and third group received glibenclamide 5mg with vitamin C 2g orally .All groups received drugs daily for 8 weeks. Investigations like Fasting blood sugar (FBS), Post prandial blood sugar(PPBS) were measured before and after vitamin C consumption and the results were analyzed. Results: A significant decrease in PPBS level was seen in both the group supplemented with 1g and 2 g of vitamin C. However percentage of reduction in Postprandial blood sugar level is more in group receiving vitamin C 2g(15.4% ,P<0.001) than group receiving 1g (9.6% ,P<0.007). Conclusions: Our result showed that oral supplementation of vitamin C 2gm with glibenclamide reduces PPBS level. Hence, supplementation of vitamin C along with oral hypoglycemic drug helps in maintaining good glycaemic control in type 2 DM patients.

| Peer-reviewed Full Article image

Author(s): Dr Rekha Nayaka M R Dr Bhagya MSattigeri


Blood sugar-glibenclamide-type 2 diabetic mellitus-Vitamin C.

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version